Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
NCT ID: NCT01536899
Last Updated: 2018-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
119 participants
OBSERVATIONAL
2012-02-29
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Several alternative hypotheses will be evaluated in the proposed project:
1. healthier patients may self-select marijuana use;
2. marijuana use may be associated with consequences that create barriers to seeking healthcare;
3. marijuana use may have medicinal value that reduces the need for such care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain, Inflammation, and Cannabis in HIV
NCT04860089
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
NCT04810858
Cannabis, HIV and Mental Processing Systems
NCT05430490
Pain Inflammation and Cannabis in HIV
NCT05554146
Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS
NCT00079560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time.
We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants will have HIV.
* Participants will sign a single consent form.
* Participants will be marijuana users.
Exclusion Criteria
* Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Wayne State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Greenwald, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Greenwald, PhD
Role: PRINCIPAL_INVESTIGATOR
Wayne State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wayne State University (HIV clinic, Tolan Park Medical Buiding)
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Woodcock EA, Greenwald MK, Chen I, Feng D, Cohn JA, Lundahl LH. HIV chronicity as a predictor of hippocampal memory deficits in daily cannabis users living with HIV. Drug Alcohol Depend Rep. 2023 Sep 13;9:100189. doi: 10.1016/j.dadr.2023.100189. eCollection 2023 Dec.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMC-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.